Abstract:Cancer immunotherapy is rapidly becoming one of the pillars of anti-cancer therapy. Unlike previous cancer therapies, immunotherapy aims at activating or enhancing the natural immune response of the patient to kill cancer cells and tissues. It means that the immune system can be activated to attack the cancer cells but leaving the normal, healthy cells intact. Immunotherapy can be realised in several treatment approaches, such as the increase of the non-specific immune system, by cancer vaccines, adoptive cell transfer and monoclonal antibodies. Considering the heterogenicity and genetic instability of tumors, a certain kind of treatment may not achieve ideal therapeutic effect all the time. In recent years, using ultrasound to achieve immune response towards cancer shows great promise. Ultrasound is one of the most commonly used imaging diagnostic techniques for cancer diseases. Besides, ultrasound has attraction for both direct US treatment and activating drug delivery due to its biological effects. Several studies suggest that ultrasound can be used to boost the host anti-tumor immune responses. The recent advances, the potential and existing problems of US induced cancer immunotherapy are reviewed. Focused ultrasound (FUS) can achieve a high US energy with in a small focal volume, which causes local destruction of tumor tissues with minimal damage to surrounding normal tissues. Destruction of tumors caused by FUS may lead to generate tumor debris and tumor-associated antigens (TAAs) in situ , which can facilitate and amplify the anti-tumor immune responses, and protect the body from tumorgenesis when re-challenged. HIFU also has effects on other than the destruction of the tissue. HIFU treatment, which triggers a Th1 type response, leads to significant changes in cell-mediated immunity. HIFU treatment also acts by balancing the cancer-induced immuno-suppression in tumor micro-environment. Microbubbles (MBs), a kind of US contrast agents, can improve the therapeutic efficacy of FUS because of their intensity reflection and scattering of ultrasonic waves, which shows great value in clinical use. The addition of MBs to FUS can help generate more local destruction in the area of focus. Combination FUS with microbubbles has been found to increase the permeability of the blood-brain barrier (BBB) and provide a temporary and targeted opening of the BBB without inflicting brain damage or inflammation, thus is an attractive means to deliver immune cells and drugs. Sonoporation is the use of sound (typically ultrasonic frequencies) for modifying the permeability of the cell plasma membrane. Sonoporation employs the acoustic cavitation of microbubbles to enhance delivery of large molecules. This technique is usually used in gene therapy and drug delivery. Another way to achieve anti-tumor immune responses is using US and MBs to deliver immune-stimulating substances to immune cells or tumor cells. Drug delivery that using a combination of MBs and US has been explored. Non-destructive US with or without MBs can increase the delivery of active substances including antigens and immune-stimulating genes. Combination of microbubbles with cell-targeting ligands and US provides an even more smart delivery system, therefore, the therapy is not only site specific but also cell specific. Overall, the use of US to achieve immune response towards cancer is showing promise. The field is fairly young and many mechanisms are still not fully understood, thus further researches are needed.

The Emergence of Cancer Sono-Immunotherapy

Translational Prospects of Ultrasound-Mediated Tumor Immunotherapy: A Review of Preclinical Advances and Safety Considerations.

Progress in application of nanomedicines for enhancing cancer sono-immunotherapy

Ultrasound Improved Immune Adjuvant Delivery to Induce DC Maturation and T Cell Activation.

Ultrasound Augmented Cancer Immunotherapy

Ultrasound-mediated Immune Regulation in Tumor Immunotherapy

Synergistic Effects of Acoustics-based Therapy and Immunotherapy in Cancer Treatment

Nanomaterials Augmented Bioeffects of Ultrasound in Cancer Immunotherapy

Progress in Nanomedicine for Sonodynamic Immunotherapy of Tumors

Advances of ultrasound in tumor immunotherapy

Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy

Synergies Between Therapeutic Ultrasound, Gene Therapy and Immunotherapy in Cancer Treatment.

Ultrasound Induced Cancer Immunotherapy

Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies

Probiotic Engineering and Targeted Sonoimmuno-Therapy Augmented by STING Agonist.

Nanosonosensitizers With Ultrasound-Induced Reactive Oxygen Species Generation for Cancer Sonodynamic Immunotherapy

Exploration of Ultrasound‐Sensitive Biomaterials in Cancer Theranostics

Organic Sonodynamic Materials for Combination Cancer Immunotherapy

Sonochemotherapy Against Cancers

Focused Ultrasound-Mediated Small-Molecule Delivery to Potentiate Immune Checkpoint Blockade in Solid Tumors

Ultrasound-Enabled Nanomedicine for Tumor Theranostics